Bulletin
Investor Alert

Market Pulse Archives

Sept. 2, 2021, 3:46 p.m. EDT

FDA committee to discuss COVID-19 booster shots

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    BioNTech SE ADR (BNTX)
  • X
    Pfizer Inc. (PFE)
  • X
    Moderna Inc. (MRNA)

or Cancel Already have a watchlist? Log In

By Jaimy Lee

An influential Food and Drug Administration advisory committee plans to meet Sept. 17 to discuss extra doses of the COVID-19 vaccines, including the application filed by BioNTech SE /zigman2/quotes/214419716/composite BNTX -5.77% and Pfizer Inc. /zigman2/quotes/202877789/composite PFE -2.33% for a third dose of their COVID-19 shot. Moderna Inc. /zigman2/quotes/205619834/composite MRNA -4.45% on Wednesday also submitted its application for a booster dose of its COVID-19 vaccine. The FDA's Vaccines and Related Biological Products Advisory Committee traditionally recommends whether the FDA should authorize or approve a vaccine or drug. The regulator is not required to follow the advice of the committee but it often does. The Biden administration previously said that COVID-19 booster shots will be available to adults starting Sept. 20, though availability will be dependent on a stamp of approval from the FDA and the Centers for Disease Control and Prevention. "The FDA will review the supplemental application as expeditiously as possible, while still doing so in a thorough and science-based manner," Dr. Peter Marks, the director of the FDA's Center for Biologics Research and Evaluation, said in a statement on Wednesday.

/zigman2/quotes/214419716/composite
US : U.S.: Nasdaq
$ 147.50
-9.03 -5.77%
Volume: 4.40M
Jan. 21, 2022 4:00p
P/E Ratio
4.26
Dividend Yield
N/A
Market Cap
$35.77 billion
Rev. per Employee
$8.48M
loading...
/zigman2/quotes/202877789/composite
US : U.S.: NYSE
$ 52.79
-1.26 -2.33%
Volume: 41.06M
Jan. 21, 2022 4:02p
P/E Ratio
15.67
Dividend Yield
3.03%
Market Cap
$296.30 billion
Rev. per Employee
$883,274
loading...
/zigman2/quotes/205619834/composite
US : U.S.: Nasdaq
$ 160.07
-7.45 -4.45%
Volume: 11.80M
Jan. 21, 2022 4:00p
P/E Ratio
9.83
Dividend Yield
N/A
Market Cap
$64.90 billion
Rev. per Employee
$9.10M
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.